Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) EBIT Margin (2016 - 2026)

OptimizeRx's EBIT Margin history spans 16 years, with the latest figure at 26.58% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 1533.0% to 26.58% in Q4 2025 year-over-year; TTM through Dec 2025 was 10.69%, a 2556.0% increase, with the full-year FY2025 number at 10.69%, up 2556.0% from a year prior.
  • EBIT Margin hit 26.58% in Q4 2025 for OptimizeRx, up from 7.86% in the prior quarter.
  • Over the last five years, EBIT Margin for OPRX hit a ceiling of 26.58% in Q4 2025 and a floor of 54.32% in Q1 2023.
  • Historically, EBIT Margin has averaged 13.64% across 5 years, with a median of 14.78% in 2024.
  • Biggest five-year swings in EBIT Margin: crashed -3404bps in 2023 and later soared 4968bps in 2024.
  • Tracing OPRX's EBIT Margin over 5 years: stood at 3.06% in 2021, then tumbled by -244bps to 4.4% in 2022, then tumbled by -774bps to 38.43% in 2023, then surged by 129bps to 11.25% in 2024, then surged by 136bps to 26.58% in 2025.
  • Business Quant data shows EBIT Margin for OPRX at 26.58% in Q4 2025, 7.86% in Q3 2025, and 10.92% in Q2 2025.